Giuseppe Roscilli

1 ta ish

1. From ex vivo to in vivo chimeric antigen T cells manufacturing: new horizons for CAR T-cell based therapy

   Eleonora Pinto, Lisa A. Lione, Mirco Compagnone +8

   Sharh maqola20253 iqtibos

   ABIABI:AkademIndex/2026.other.475954